(Q37222641)

19 August 2017

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband (English)

1 reference

19 August 2017

2

C Cybulski

1 reference

19 August 2017

13

J Lubinski

1 reference

19 August 2017

6

T Byrski

1 reference

19 August 2017

14

S A Narod

1 reference

19 August 2017

1

J Gronwald

1 reference

19 August 2017

5

T Huzarski

1 reference

19 August 2017

4

J Suchy

1 reference

19 August 2017

7

B Gorski

1 reference

19 August 2017

9

M Szwiec

1 reference

19 August 2017

8

T Debniak

1 reference

19 August 2017

W Piesiak

3

1 reference

19 August 2017

D Wokolowczyk

series ordinal

10

1 reference

19 August 2017

M Matuszewski

series ordinal

11

1 reference

19 August 2017

P Sun

series ordinal

12

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

British Journal of Cancer

19 August 2017

1 reference

19 August 2017

100

1 reference

19 August 2017

9

1 reference

19 August 2017

1508-1512

1 reference

Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

CHEK2 is a multiorgan cancer susceptibility gene

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

A novel founder CHEK2 mutation is associated with increased prostate cancer risk

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

Re: On the use of familial aggregation in population-based case probands for calculating penetrance.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

On the use of familial aggregation in population-based case probands for calculating penetrance.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2694428

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605038

CHEK2 mutation and hereditary breast cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19401704

12 December 2020

inferred from PubMed ID database lookup

Epistatic relationship between the cancer susceptibility genes CHEK2 and p27

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19401704

12 December 2020

inferred from PubMed ID database lookup

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19401704

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/SJ.BJC.6605038

1 reference

release_f3n4gxfvmzh23aeq6crmjleqki

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f3n4gxfvmzh23aeq6crmjleqki

24 November 2022

mapped directly with Wikidata item

1 reference

19 August 2017

PubMed publication ID

19401704

1 reference